These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7337432)

  • 1. Absence of a correlation between humoral and cellular responses to a vaccinia virus and products of the major histocompatibility complex in rhesus monkeys.
    Stitz L; Kreeftenberg JG; Loggen HG; Balner H
    Antiviral Res; 1981 Sep; 1(3):193-9. PubMed ID: 7337432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of humoral immunity and induction of proliferating T lymphocytes in vaccinia virus-infected rabbits and rhesus macaques.
    Schäffner JW; Dittmer U; Otteken A; Coulibaly C; Bodemer W; Voss G; Hunsmann G
    Am J Vet Res; 1994 Sep; 55(9):1250-5. PubMed ID: 7802392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response against vaccinia virus in rhesus monkeys: no evidence for primary MHC-restricted cytolytic T cells.
    Stitz L; Zinkernagel R; Balch CM; Bolhuis RL; Balner H
    Exp Cell Biol; 1984; 52(4):237-50. PubMed ID: 6610578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo immune stimulation by interferon during viral infection.
    Schellekens H; Weimar W; De Reus A; Bolhuis RL; Cantell K
    Antiviral Res; 1981 Sep; 1(3):179-83. PubMed ID: 6175277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No reactivation of attenuated immunodeficiency viruses in rhesus macaques after vaccinia virus-induced immune activation.
    Dittmer U; Nisslein T; Meyerhans A; Hunsmann G; Stahl-Hennig C
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2523-8. PubMed ID: 9349473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate.
    Kantor J; Irvine K; Abrams S; Snoy P; Olsen R; Greiner J; Kaufman H; Eggensperger D; Schlom J
    Cancer Res; 1992 Dec; 52(24):6917-25. PubMed ID: 1458480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Testing the immunity to orthopoxviruses in the white mouse with vaccinia virus].
    Czerny CP; Mahnel H; Hornstein O
    Zentralbl Veterinarmed B; 1989 Mar; 36(2):100-12. PubMed ID: 2750360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous HIV-2 challenge of rhesus monkeys immunized with recombinant vaccinia viruses and purified recombinant HIV-2 proteins.
    Vogt G; le Grand R; Vaslin B; Boussin F; Auboyer MH; Rivière Y; Putkonen P; Sonigo P; Kieny MP; Girard M
    Vaccine; 1995 Feb; 13(2):202-8. PubMed ID: 7625117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses.
    Spriggs MK; Koller BH; Sato T; Morrissey PJ; Fanslow WC; Smithies O; Voice RF; Widmer MB; Maliszewski CR
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6070-4. PubMed ID: 1631092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus.
    Schmitz JE; Kuroda MJ; Santra S; Simon MA; Lifton MA; Lin W; Khunkhun R; Piatak M; Lifson JD; Grosschupff G; Gelman RS; Racz P; Tenner-Racz K; Mansfield KA; Letvin NL; Montefiori DC; Reimann KA
    J Virol; 2003 Feb; 77(3):2165-73. PubMed ID: 12525651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro immune responsiveness to vaccinia virus and HLA.
    de Vries RP; Kreeftenberg HG; Loggen HG; van Rood JJ
    N Engl J Med; 1977 Sep; 297(13):692-6. PubMed ID: 70749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and cell-mediated immune responses in humans before and after revaccination with vaccinia virus.
    Møller-Larsen A; Haahr S
    Infect Immun; 1978 Jan; 19(1):34-9. PubMed ID: 624594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing antibody titers following revaccination with vaccinia virus.
    Heering SL; Shohat T; Vonsover A; Mendelson E; Lerman Y
    Public Health Rev; 1990-1991; 18(1):94-7. PubMed ID: 2132886
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara.
    Nilsson C; Mäkitalo B; Berglund P; Bex F; Liljeström P; Sutter G; Erfle V; ten Haaft P; Heeney J; Biberfeld G; Thorstensson R
    Vaccine; 2001 May; 19(25-26):3526-36. PubMed ID: 11348720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.
    Davies DH; McCausland MM; Valdez C; Huynh D; Hernandez JE; Mu Y; Hirst S; Villarreal L; Felgner PL; Crotty S
    J Virol; 2005 Sep; 79(18):11724-33. PubMed ID: 16140750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination.
    Barouch DH; Santra S; Kuroda MJ; Schmitz JE; Plishka R; Buckler-White A; Gaitan AE; Zin R; Nam JH; Wyatt LS; Lifton MA; Nickerson CE; Moss B; Montefiori DC; Hirsch VM; Letvin NL
    J Virol; 2001 Jun; 75(11):5151-8. PubMed ID: 11333896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cyclophosphamide on intracerebral vaccinia virus infection in Balb/C mice.
    Ginsberg AH; Johnson KP
    Exp Mol Pathol; 1977 Dec; 27(3):285-94. PubMed ID: 923746
    [No Abstract]   [Full Text] [Related]  

  • 18. Humoral immune response elicited by highly attenuated variants of vaccinia virus and by an attenuated recombinant expressing HIV-1 envelope protein.
    Dallo S; Maa JS; Rodriguez JR; Rodriguez D; Esteban M
    Virology; 1989 Nov; 173(1):323-9. PubMed ID: 2510402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV.
    Fuller DH; Simpson L; Cole KS; Clements JE; Panicali DL; Montelaro RC; Murphey-Corb M; Haynes JR
    Immunol Cell Biol; 1997 Aug; 75(4):389-96. PubMed ID: 9315483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of H-2 antigenic sites by enzymatic treatment influences virus-specific target cell lysis.
    Ertl HC; Koszinowski UH
    J Immunol; 1976 Dec; 117(6):2112-8. PubMed ID: 993596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.